John Oliver Warns of Doctors in Bed With Big Pharma, Offers Tools to Spot Them
The "Last Week Tonight" host is back from hiatus with a scathing rebuke of doctors whose influence is bought by the pharmaceutical industry.The “Last Week Tonight” host is back from hiatus with a scathing rebuke of doctors whose influence is bought by the pharmaceutical industry. After his customary rant, Oliver ran an honest pharmaceutical commercial about the industry’s relationship with doctors and pointed out a new website that can help patients find out more about who’s contributing money to their doctors.
—Posted by Natasha Hakimi Zapata
Strong Journalism, Rooted in TruthTruthdig remains committed to deep reporting that challenges power and brings hidden stories to the surface.
Support independent journalism.
Related Stories
Books
A new book explains why drugs cost so much in the United States — and why Trump’s claims about addressing the crisis are bogus.
Health & Wellness
Drugmakers claim that broad state PFAS laws are overly burdensome. But environmental health experts aren’t convinced.
Economic Justice
2025 marked the first time in two decades that the annual cost of covering a family of four rose by 6% or more for three consecutive years.
TD Original
Gilead’s price drop for the HIV prevention drug lenacapavir is a smoke screen for monopoly medicine.
Health & Wellness
Critics say ending the decades-old practice would likely shield the agency’s decisions from public scrutiny.
Health & Wellness
The pharmaceutical industry has long had outsize influence over government policy. Now wellness influencers are having their way.
Books
A new book explains why drugs cost so much in the United States — and why Trump’s claims about addressing the crisis are bogus.
Health & Wellness
Drugmakers claim that broad state PFAS laws are overly burdensome. But environmental health experts aren’t convinced.
Economic Justice
2025 marked the first time in two decades that the annual cost of covering a family of four rose by 6% or more for three consecutive years.
TD Original
Gilead’s price drop for the HIV prevention drug lenacapavir is a smoke screen for monopoly medicine.
Health & Wellness
Critics say ending the decades-old practice would likely shield the agency’s decisions from public scrutiny.
Health & Wellness
The pharmaceutical industry has long had outsize influence over government policy. Now wellness influencers are having their way.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.